Biliary Cholangitis
📧 Sign up to get email alerts when something new happens for Biliary Cholangitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-07-16Clinical Trial Results: Study of OCA in Combination With BZF Evaluating Efficacy, Safety, and Tolerability in Participants With PBC [Phase 2]
Phase 2 trial investigating obeticholic acid (OCA) in combination with BZF for efficacy, safety, and tolerability in primary biliary cholang…
-
CLINICAL_TRIALS trial_result · 2026-07-16Clinical Trial Results: Study of OCA in Combination With BZF Evaluating Efficacy, Safety and Tolerability in Participants With PBC [Phase 2]
Phase 2 clinical trial evaluating obeticholic acid (OCA) in combination with an additional agent (BZF) for primary biliary cholangitis; stud…
-
CLINICAL_TRIALS trial_result · 2026-07-09Clinical Trial Update: A Study of Elafibranor in Adults With Primary Biliary Cholangitis and Inadequate Response or Intolerance to Ursodeoxycholic Acid. [Phase 3]
Phase 3 trial update for elafibranor in adults with primary biliary cholangitis who had inadequate response or intolerance to ursodeoxycholi…
-
CLINICAL_TRIALS trial_result · 2026-07-02Clinical Trial Update: A Study of Elafibranor in Adults With Primary Biliary Cholangitis and Inadequate Response or Intolerance to Ursodeoxycholic Acid. [Phase 3]
A Phase 3 clinical trial investigating elafibranor in adults with primary biliary cholangitis and inadequate response or intolerance to urso…
-
CLINICAL_TRIALS trial_result · 2026-06-08Clinical Trial Results: To Evaluate Safety and Tolerability of the Fixed- Dose Combination of Obeticholic Acid and Bezafibrate [Phase 3]
Phase 3 trial evaluating safety and tolerability of a fixed-dose combination of obeticholic acid and bezafibrate in primary biliary cholangi…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-06-04Clinical Trial Update: Intended to Determine the Effects of Seladelpar on Normalization of Alkaline Phosphatase Levels in Subjects With Primary Biliary Cholangitis (PBC) [Phase 3]
Phase 3 trial update assessing seladelpar's effect on normalizing alkaline phosphatase in primary biliary cholangitis.
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Clinical Characterization of Patients With Primary Biliary Cirrhosis Treated With Seladelpar in the Real-life Setting
This clinical trial update describes the real-world characterization of patients with primary biliary cholangitis treated with seladelpar, w…
-
CLINICAL_TRIALS trial_result · 2026-04-02Clinical Trial Update: A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Biliary Cholangitis [Phase 2]
A Phase 2 study is evaluating the efficacy and safety of the investigational drug Volixibat for pruritus in patients with Primary Biliary Ch…
-
CLINICAL_TRIALS trial_result · 2026-04-01Clinical Trial Update: A Study Describing Scratch and Sleep Patterns in Patients With Primary Biliary Cholangitis (Luminaria)
Completed clinical trial update describing scratch and sleep patterns in patients with Primary Biliary Cholangitis (Luminaria), sponsored by…
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: A Study Observing Everyday Effectiveness and Safety of the Drug Elafibranor in Participants With Primary Biliary Cholangitis Who Are Receiving Ongoing Treatment
Ipsen is conducting a clinical study to observe the everyday effectiveness and safety of Elafibranor in participants with Primary Biliary Ch…
-
CLINICAL_TRIALS trial_result · 2026-04-01Clinical Trial Update: Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis [Phase 3]
Seladelpar is being evaluated in a Phase 3 trial for primary biliary cholangitis with compensated cirrhosis and is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Cholangitis [Phase 3]
Ipsen's long-term Phase 3 trial is evaluating elafibranor in adults with primary biliary cholangitis and is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: A Study of Elafibranor in Adult Japanese Participants With Primary Biliary Cholangitis (PBC) [Phase 3]
Phase 3 study evaluating elafibranor in adult Japanese participants with Primary Biliary Cholangitis; the trial is currently active but not …
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: A Study of Elafibranor in Adults With Primary Biliary Cholangitis and Inadequate Response or Intolerance to Ursodeoxycholic Acid. [Phase 3]
This is a Phase 3 clinical trial update for elafibranor in adults with primary biliary cholangitis; the study investigates those with inadeq…
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: Liver-gut Axis Study Through Identification of Liver Disease-specific Microbiome
A recruiting clinical trial is examining the liver-gut axis by identifying liver disease–specific microbiome patterns. The study covers auto…
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: CS0159 in Chinese Patients With PBC (Primary Biliary Cholangitis) [Phase 2]
A Phase 2 clinical trial of CS0159 for primary biliary cholangitis in Chinese patients is currently active but not recruiting, sponsored by …
-
CLINICAL_TRIALS trial_result · 2026-03-10Clinical Trial Update: Study to Evaluate the Safety, Tolerability, PDs, and Efficacy of CNP-104 in Subjects With Primary Biliary Cholangitis [Phase 1, Phase 2]
A completed Phase 1/2 clinical trial evaluating the safety, tolerability, pharmacodynamics, and efficacy of CNP-104 in subjects with Primary…
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: A Two-part Study to Investigate the Effects in Adults of Two Doses of Golexanolone in Patients With Primary Biliary Cholangitis (PBC) With Fatigue and Cognitive Dysfunction [Phase 1, Phase 2]
This clinical trial update describes a two-part Phase 1/Phase 2 study evaluating two doses of golexanolone in adults with primary biliary ch…
-
CLINICAL_TRIALS trial_result · 2026-03-04Clinical Trial Update: Biochemical Response and Clinical Outcomes in Patients With PBC
This entry notes ongoing recruitment for a study evaluating biochemical response and clinical outcomes in patients with Primary Biliary Chol…
-
CLINICAL_TRIALS research · 2026-02-20Clinical Trial Update: Study of Saroglitazar Magnesium for PBC Patients With Incomplete Response or Intolerant to UDCA Therapy [Phase 3]
A Phase 3 clinical trial studying saroglitazar magnesium for Primary Biliary Cholangitis patients who have incomplete response or intoleranc…
-
CLINICAL_TRIALS research · 2026-02-18Clinical Trial Update: A 5-year Longitudinal Observational Study of Patients With Primary Biliary Cholangitis
A 5-year longitudinal observational study of patients with primary biliary cholangitis has completed, sponsored by Target PharmaSolutions, I…
-
CLINICAL_TRIALS research · 2026-02-18Clinical Trial Update: Long-Term Study to Evaluate the Safety and Efficacy in Participants With Primary Biliary Cholangitis of Saroglitazar Magnesium-V on Clinical Outcomes [Phase 3]
Phase 3 long-term study to evaluate the safety and efficacy of Saroglitazar Magnesium-V in participants with Primary Biliary Cholangitis; tr…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Biobank for Cholestatic Liver Diseases.
Mayo Clinic is recruiting for a biobank study of cholestatic liver diseases, including primary sclerosing cholangitis and primary biliary ch…
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: Open-Label Extension Study of Saroglitazar Magnesium in Participants With Primary Biliary Cholangitis [Phase 3]
An open-label extension study (Phase 3) of saroglitazar magnesium in participants with primary biliary cholangitis, currently recruiting.
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: Fenofibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cholangitis [Phase 2, Phase 3]
This clinical trial update describes a Phase 2/Phase 3 study evaluating fenofibrate in combination with ursodeoxycholic acid for primary bil…